Among them, five signaling pathways, such as PPAR and PPARα/RXRα activation, were significantly downregulated, and the cardiac hypertrophy signaling, pulmonary fibrosis idiopathic signaling pathway, and S100 family signaling pathway were significantly upregulated (Table S6, Figure 5b). The gene discussed is PPARA; the disease is cardiac hypertrophy.